Related Experiment Video
Updated: Aug 19, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Transcriptional profiling identifies gene expression changes associated with IFN-alpha tolerance in hepatitis
Nathalie Wong1, Kathy Y-Y Chan, Pascale F Macgregor
1Department of Anatomical and Cellular Pathology, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, N.T., Hong Kong. natwong@cuhk.edu.hk
Purpose:
Treatment with IFN-alpha therapy has been shown to exhibit antitumor effects on patients with hepatocellular carcinoma (HCC). However, individual responses remained unpredictable because of the frequent presence of intrinsic or acquired IFN-alpha resistance. Hence, delineation of molecular targets implicated in the resistant pathway holds value in refining the therapeutic benefits of IFN-alpha.
Experimental Design:
The current study analyzed the effect of IFN-alpha in human HCC cells. Three hepatitis C virus (HCV)-related, five hepatitis B virus (HBV)-related and two non-B non-C-related cell lines were subjected to IFN-alpha treatment and the cytotoxic effect on cell viability was measured. Further analysis by cDNA microarray and quantitative reverse transcription-PCR were conducted to examine the gene expression changes that mediated the IFN-alpha resistance observed.
Results:
According to the IC(50) values determined, HCV-related cell lines indicated distinct resistance (IC(50), 389-1468 units/mL) compared with the HBV-related (IC(50), 11-77 units/mL) and non-B non-C-related cell lines (IC(50), 24-108 units/mL). Unsupervised hierarchical clustering on array data indicated three HCV-related cell lines to cluster independently from the sensitive cell lines, suggesting discrete features in association with IFN-alpha tolerance. Moreover, Significance Analysis of Microarrays analysis indicated the differential expression of 149 expressed sequence tags that represented 51 up-regulated and 98 down-regulated genes in the resistant cell lines. Comparing the temporal pattern of gene expression between 6- and 24-hour treatments, candidate genes that were considerably induced with time were further highlighted in the tolerant HCV-related cell lines. These candidates were verified by quantitative reverse transcription-PCR, which confirmed the down-regulation of UBA2, ZNF185, and FOXF1 and up-regulation of UBE4B in the drug-tolerant cells.
Conclusions:
Our present study showed that the insensitivity to IFN-alpha therapy in HCC cells is associated with drug-inducible transcriptional alterations. Furthermore, our investigation highlighted potential candidate genes in conferring an anti-apoptotic effect toward IFN-alpha treatment.
Insights
Hepatocellular carcinoma (HCC) cells show resistance to interferon-alpha (IFN-alpha) therapy due to drug-inducible gene expression changes. Identifying these molecular targets could improve HCC treatment outcomes.
Area of Science:
- Hepatocellular Carcinoma Research
- Cancer Therapeutics
- Molecular Biology
Background:
- Interferon-alpha (IFN-alpha) therapy shows antitumor effects in hepatocellular carcinoma (HCC).
- Predicting individual patient response to IFN-alpha is challenging due to resistance.
- Understanding IFN-alpha resistance mechanisms is crucial for optimizing HCC treatment.
Purpose of the Study:
- To analyze the effect of IFN-alpha on human HCC cells.
- To identify molecular targets and gene expression changes associated with IFN-alpha resistance.
- To explore potential therapeutic strategies for overcoming IFN-alpha resistance in HCC.
Main Methods:
- Treatment of various human HCC cell lines (HCV-related, HBV-related, non-B non-C-related) with IFN-alpha.
- Assessment of cytotoxic effects on cell viability using IC50 values.
- Gene expression profiling via cDNA microarray and quantitative reverse transcription-PCR.
Main Results:
- HCV-related HCC cell lines exhibited significantly higher resistance to IFN-alpha compared to HBV-related and non-B non-C-related cell lines.
- Hierarchical clustering revealed distinct molecular features in IFN-alpha-tolerant HCV-related cell lines.
- Differential expression analysis identified 149 genes (51 up-regulated, 98 down-regulated) associated with IFN-alpha resistance, including UBA2, ZNF185, FOXF1, and UBE4B.
Conclusions:
- IFN-alpha insensitivity in HCC cells is linked to drug-inducible transcriptional alterations.
- Specific candidate genes may confer an anti-apoptotic effect, contributing to IFN-alpha resistance.
- Further research into these identified genes could lead to improved IFN-alpha-based therapies for HCC.
Related Concept Videos
Cell Specific Gene Expression
Hepatitis
General Transcription Factors
Inhibitors of Viral Protein Synthesis
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...

